STUB1 and congenital secretory chloride diarrhea 1: Collectively, these observations highlight CHIP not only as a contributor to CLD progression but also as a potential biomarker for refining MASLD risk stratification, especially in patients with advanced fibrosis or increased cancer susceptibility.